These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20636481)

  • 1. Severe transfusion-transmitted parvovirus B19 infection in a naive immunocompromised patient.
    Brodin-Sartorius A; Mekki Y; Pastural M; Billaud G; Daoud S; Chauvet C; Touraine JL; Lina B; Morelon E; Thaunat O
    Transpl Infect Dis; 2011 Feb; 13(1):97-8. PubMed ID: 20636481
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parvovirus B19 infection: diagnosing and treating a kidney transplant patient].
    León LR; Curcio D; Casadei D
    Nefrologia; 2010; 30(6):704. PubMed ID: 21113225
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosing human parvovirus B19 infection: guidelines for test selection.
    Jordan JA
    Mol Diagn; 2001 Dec; 6(4):307-12. PubMed ID: 11774195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parvovirus B19 infection and its clinical picture].
    Dudina KR; Znoĭko OO; Iushchuk ND
    Ter Arkh; 2007; 79(11):75-8. PubMed ID: 18219981
    [No Abstract]   [Full Text] [Related]  

  • 5. No apparent difference in the prevalence of parvovirus B19 infection between chronic fatigue syndrome patients and healthy controls in Japan.
    Kato YH; Yamate M; Tsujikawa M; Nishigaki H; Tanaka Y; Yunoki M; Kuratsune H; Watanabe Y; Ikuta K
    J Clin Virol; 2009 Mar; 44(3):246-7. PubMed ID: 19200778
    [No Abstract]   [Full Text] [Related]  

  • 6. Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients.
    Jordan J; Tiangco B; Kiss J; Koch W
    Vox Sang; 1998; 75(2):97-102. PubMed ID: 9784661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
    Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
    Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic parvovirus infection.
    Koduri PR
    Am J Hematol; 2006 Sep; 81(9):721. PubMed ID: 16838321
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
    Braham S; Gandhi J; Beard S; Cohen B
    J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence and significance of parvovirus B19 in blood and blood products.
    Siegl G; Cassinotti P
    Biologicals; 1998 Jun; 26(2):89-94. PubMed ID: 9811511
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged fever caused by parvovirus B19-induced meningitis: case report and review.
    Tabak F; Mert A; Ozturk R; Koksal V; Akbas I; Aktuglu Y
    Clin Infect Dis; 1999 Aug; 29(2):446-7. PubMed ID: 10476760
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rheumatoid arthritis and human parvovirus B 19].
    Sasaki T
    Ryumachi; 1999 Dec; 39(6):867-73. PubMed ID: 10695412
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistence of parvovirus B19 IgM antibodies and DNA in pure red cell aplasia resulting in myelodysplasia--a case report.
    Kishore J; Mukhopadhyay C
    Indian J Pathol Microbiol; 2004 Jan; 47(1):78-81. PubMed ID: 15471143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
    Cassinotti P; Burtonboy G; Fopp M; Siegl G
    J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland.
    Grabarczyk P; Kalińska A; Kara M; Wieczorek R; Ejduk A; Sulkowska E; Gołębiowska-Staroszczyk S; Matysiak M; Baylis SA; Brojer E
    J Med Virol; 2011 Jan; 83(1):142-9. PubMed ID: 21108352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and review.
    Lowenthal EA; Wells A; Emanuel PD; Player R; Prchal JT
    Am J Hematol; 1996 Mar; 51(3):207-13. PubMed ID: 8619401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal involvement of human parvovirus B19 in an immunocompetent host.
    Taylor G; Drachenberg C; Faris-Young S
    Clin Infect Dis; 2001 Jan; 32(1):167-9. PubMed ID: 11106317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent pure red cell aplasia due to parvovirus B19 infection in a patient with Turner's syndrome.
    Pitchaipillai S; Kelsey P; Haeney M
    Clin Lab Haematol; 2006 Oct; 28(5):347-50. PubMed ID: 16999728
    [No Abstract]   [Full Text] [Related]  

  • 19. Meningoencephalitis associated with human parvovirus B19.
    Coskun O; Erdem H; Gul HC; Besirbellioglu BA; Sener K; Eyigun CP
    Clin Microbiol Infect; 2008 Dec; 14(12):1188-90. PubMed ID: 19076847
    [No Abstract]   [Full Text] [Related]  

  • 20. Significant decrease in hemoglobin and hematocrit levels in a virologically controlled HIV-infected patient. Pure red cell aplasia (PRCA) caused by human parvovirus B19.
    Naval-Srinivas RM; Church LW
    AIDS Read; 2003 Apr; 13(4):189. PubMed ID: 12741369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.